No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $154.43
BioNTech SE's Strategic and Clinical Advancements Drive Buy Rating on BNT327's Promise in Oncology
J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating, Announces Target Price $122
J.P. Morgan Reaffirms Their Hold Rating on BioNTech SE (BNTX)
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)